Related Experiment Video
Updated: Dec 13, 2025
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Gene expression profile analysis of the rabbit retinal vein occlusion model
Takuma Neo1, Makoto Gozawa2, Yoshihiro Takamura2
1Department of Applied Chemistry and Biotechnology, Graduate School of Engineering, University of Fukui, Fukui, Japan.
Abstract:
The rabbit retinal vein occlusion (RVO) model is an experimental system that mimics retinal ischemic diseases in humans. The rabbit RVO model is widely used to assess the therapeutic efficacy of various experimental surgical procedures. In the present study, we measured temporal retinal expression of Vegfa, which is known as an ischemic response gene, in rabbit RVO. This analysis revealed that the retinal Vegfa transcriptional response began 7 days after generation of RVO, rather than immediately after induction of ischemia. Next, in order to analyze ischemia-induced changes in gene expression profiles, we performed microarray analysis of day 7 RVO retina versus control retina. The angiogenic regulators Dcn and Mmp1 and pro-inflammatory factors Mmp12 and Cxcl13 were significantly upregulated in RVO retinas. Further, we suggest that epigenetic regulation via the REST/cofactor-complex could contribute to RVO pathology. Among human homologous genes in rabbits, genes associated with hypoxia, angiogenesis, and inflammation were significantly upregulated in RVO retinas. Components of the Tumor necrosis factor-alpha (TNFα) and Nuclear factor-kappa B (NF-κB) pathways, which play regulatory roles in angiogenesis and inflammation, were significantly upregulated in RVO, and the expression levels of downstream factors, such as the transcription factor AP-1 and chemokines, were increased. Further, connectivity map analyses suggested that inhibitors of the NF-κB pathway are potential therapeutic agents for retinal ischemic disease. The present study revealed new insights into the pathology of retinal ischemia using the rabbit RVO model, which accurately recapitulates human disease.
Insights
The rabbit retinal vein occlusion model reveals delayed Vegfa response and identifies key angiogenic and inflammatory genes. NF-κB pathway inhibitors show potential for treating retinal ischemia.
Area of Science:
- Ophthalmology
- Molecular Biology
- Pathology
Background:
- Retinal vein occlusion (RVO) is a significant cause of vision loss.
- The rabbit RVO model is crucial for studying retinal ischemia and evaluating therapies.
- Understanding the molecular mechanisms of RVO is essential for developing effective treatments.
Purpose of the Study:
- To investigate the temporal expression of Vegfa in a rabbit RVO model.
- To analyze gene expression profiles in RVO retinas to identify key molecular players.
- To explore potential therapeutic targets for retinal ischemic diseases.
Main Methods:
- Induction of RVO in rabbits and temporal monitoring of Vegfa expression.
- Microarray analysis to compare gene expression in RVO versus control retinas.
- Analysis of angiogenic, inflammatory, and epigenetic pathways, including TNFα and NF-κB signaling.
Main Results:
- Vegfa transcriptional response initiated 7 days post-RVO, not immediately after ischemia.
- Significant upregulation of angiogenic regulators (Dcn, Mmp1) and pro-inflammatory factors (Mmp12, Cxcl13) in RVO retinas.
- Activation of TNFα and NF-κB pathways, with increased expression of downstream factors like AP-1 and chemokines.
Conclusions:
- The rabbit RVO model effectively recapitulates human retinal ischemic disease pathology.
- Epigenetic regulation via REST/cofactor-complex may contribute to RVO.
- NF-κB pathway inhibitors are identified as potential therapeutic agents for retinal ischemic diseases.
